Morgan Stanley Remains Sidelined on Square (SQ) Following Announced $750M Debt Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Morgan Stanley Remains Sidelined on Square (SQ) Following Announced $750M Debt Offering
May 21, 2018 4:22 PM EDT
Square, Inc. (NYSE: SQ) today announced its intention to offer, subject to market conditions and other factors, $750 million aggregate principal amount of convertible senior notes due in 2023 (the Notes) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of... More
May 18, 2018 9:28 AM EDT
Today's Pre-Open Movers
Agile Therapeutics, Inc., (Nasdaq: AGRX) 60% LOWER; announced the content of the official minutes from its Type A meeting with the U.S. Food and Drug Administration (FDA) held on April 16, 2018 to discuss the complete response letter (CRL) issued by the FDA on December 21, 2017 relating to the New Drug Application (NDA) for Twirla (AG200-15), the Companys investigational low-dose, non-daily, combination hormonal contraceptive patch. In the CRL, the FDA informed the Company that the Twirla NDA could not be approved due to deficiencies related to... More
May 18, 2018 8:05 AM EDT
Square (NYSE: SQ) is down 1.8% in pre-open trade after PayPal (NASDAQ: PYPL) agreed to acquire European rival iZettle for $2.2 billion.
Morgan Stanley analyst James Faucette said the deal is likely to be a check on SQ's international... More
